SATRALIZUMAB
UNII YB18NF020M

Substance Identification & Data

This profile provides standardized clinical and technical data for Satralizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YB18NF020M.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1535963-91-7 and the RxNorm Concept ID (RxCUI) 2391541. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

YB18NF020M

CAS Registry Number

1535963-91-7

RxNorm Concept ID

2391541

Detailed Substance Profile

Preferred Name

SATRALIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

YB18NF020M

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C152307

National Cancer Institute reference terminology for clinical and research data.

INN ID

10065

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-75

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Satralizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SAPELIZUMAB

SATRALIZUMAB

SATRALIZUMAB-MWGE

Common Names & Synonyms

HUMANISED ANTI-IL-6 RECEPTOR MONOCLONAL ANTIBODY

IMMUNOGLOBULIN G2, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL SA237 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SA237 LIGHT CHAIN, DIMER

SATRALIZUMAB [INN]

SATRALIZUMAB [JAN]

SATRALIZUMAB [MI]

SATRALIZUMAB [USAN]

SATRALIZUMAB [WHO-DD]

SATRALIZUMAB MWGE [WHO-DD]

Brand / Trade Names

ENSPRYNG

Systematic Nomenclature

IMMUNOGLOBULIN G2-KAPPA, ANTI-(HUMAN INTERLEUKIN-6 RECEPTOR SUBUNIT ALPHA (IL-6RA, MEMBRANE GLYCOPROTEIN 80, CD126 ANTIGEN)) HUMANIZED MONOCLONAL ANTIBODY: .GAMMA.2 HEAVY CHAIN (1-443) (HUMANIZED VH (HOMO SAPIENS IGHV4-59*01 (76%) (IGHD)-IGHJ4*01 (92%)) (9.7.12) (1-119)-HOMO SAPIENS IGHG2*01 (CH1 C14>S(133), R16>K(135), E20>G(139), S21>G(140) H C4>S(221) CH2 H37>Q(266) CH3 R15>Q(353), Q79>E(417), N94>A(432), G106>-(444), K107>-(445)) (120-443)) (222-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV1-33*01 (82%) IGKJ2*01 (83%) (6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')) DIMER (225-225'':228-228'')-BISDISULFIDE

SYS